Percutaneous coronary intervention in st-elevation myocardial infarction
- Thomas J. Ryan MD
- … show all 1 hide
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
This review traces the development of coronary angioplasty as a direct, primary means of establishing reperfusion in an acutely occluded infarct-related artery. As a therapeutic strategy for the early management of patients with ST-elevated acute myocardial infarction, this mechanical-invasive procedure arose virtually simultaneously with the demonstration that intravenous administration of fibrinolytic agents to such patients results in a relative reduction in early mortality by as much as 25% to 30%. Over the past 15 years, more than a dozen randomized, controlled trials have investigated the question, "Which is the better means of administrating reperfusion therapy?" The recent demonstration that the combination of coronary stenting plus glycoprotein IIb/IIIa inhibitors used in the early stages of ST-elevation acute myocardial infarction salvages more myocardium than the administration of front-loaded tissue plasminogen activator offers a convincing answer. This is further supported by the evidence that clinical outcomes also improved in these patients, with the greater improvement in ventricular function. It is likely, however, that the development of newer pharmacologic agents plus the combination of both strategies will keep this a hotly debated issue for some time to come.
- Meyer J, Merx W, Schmitz H: Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction. Circulation 1982, 66:905–913.
- Hartzler GO, Rutherford BD, McConahay DR, et al.: Percutaneous coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J 1983, 106:965–973. CrossRef
- White HD, Norris R, Brown MA, et al.: Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction. N Engl J Med 1987, 317:850–855. CrossRef
- Kennedy JW, Martin FV, Davis KB, et al.: The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial. Circulation 1988, 77:345–352.
- Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986, 1:397–402.
- ISIS-2 (Second International Study of Infarct Survival) Collaborative Group: Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988, 2:349–360.
- Topol EJ, Califf RM, George BS, et al.: The Thrombolysis and Angioplasty in Myocardial Infarction Study Group: a randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 1987, 317:581–588. This randomized trial arrived at conclusions that overturned conventional wisdom regarding the role of PTCA in reperfusion therapy. CrossRef
- Simoons ML, Betriu A, Col J, et al.: Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet 1988, 1:197–202. This randomized trial arrived at conclusions that overturned conventional wisdom regarding the role of PTCA in reperfusion therapy independent of Topol et al. [7 ] and The TIMI Study Group [9 ]. CrossRef
- The TIMI Study Group: Immediate versus delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction: TIMI II A results. JAMA 1988, 260:2849–2858. One of three randomized trials to arrive at conclusions that overturned conventional wisdom regarding the role of PTCA in reperfusion therapy. CrossRef
- O’Keefe JH, Rutherford BD, McConahay DR, et al.: Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1989, 64:1221–1230. CrossRef
- Stone GW, Rutherford BD, McConahay DR, et al.: Direct coronary angioplasty in acute myocardial infarction: outcome in patients with single vessel disease. J Am Coll Cardiol 1990, 15:534–543. CrossRef
- Kander NH, O’Neill W, Topol EJ, et al.: Long-term follow-up of patients with coronary angioplasty for acute myocardial infarction. Am Heart J 1980, 118:228–233. CrossRef
- Grines CL, Browne KF, Marco J, et al.: A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction: the primary angioplasty in myocardial infarction study group. N Engl J Med 1993, 328:673–679. CrossRef
- Zijlstra F, de Boer MJ, Hoorntje JC, et al.: A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993, 328:680–684. CrossRef
- Gibbons RJ, Holmes DR, Reeder GS, et al.: Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993, 328:685–691. CrossRef
- Ribeiro EE, Silva LA, Carneiro R, et al.: Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol 1993, 22:376–380. CrossRef
- The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes GUSTO IIb Angioplasty Substudy Investigators: a clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997, 336:1621–1628. The single largest randomized trial comparing PCI with fibrinolytic therapy in acute MI, and conducted largely in community hospitals versus academic medical centers. Contains some sobering observations.
- Weaver WD, Simes J, Betriu A, et al.: Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. JAMA 1997, 278:2093–2098. CrossRef
- Ryan TJ, Ryan TJ Jr., Jacobs AK: Primary PTCA versus thrombolytic therapy: an evidence-based summary. Am Heart J 1999, 138:S96-S104. CrossRef
- O’Neill W, Timmis GC, Bourdillon PD, et al.: A prospective randomized clinical trial of intracoronary streptokinase versus coronary angioplasty for acute myocardial infarction. N Engl J Med 1986, 314:812–818. CrossRef
- Ryan TJ: Thrombolysis and angioplasty in acute myocardial infarction [letter]. N Engl J Med 1998, 318:579.
- Serruys PW, de Jaegere P, Kiemeneij F, et al.: A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994, 331:489–495. CrossRef
- Schömig A, Neumann FJ, Kastrati A, et al.: A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents. N Engl J Med 1996, 334:1084–1089. A study of seminal importance. CrossRef
- Schömig A, Neumann FJ, Walter H, et al.: Coronary stent placement in patients with acute myocardial infarction: c omparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy. J Am Coll Cardiol 1997, 29:28–34. CrossRef
- Brener SJ, Barr LA, Burchenal JEB, et al.: Randomized, placebocontrolled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation 1998, 98:734–741.
- Saito S, Hosokawa G, Tanaka S, et al.: Primary stent implantation is superior to balloon angioplasty in acute myocardial infarction: final results of the Primary Angioplasty Versus Stent Implantation in Acute Myocardial Infarction (PASTA) Trial. Cathet Cardiovasc Intervent 1999, 48:262–268. CrossRef
- Kastrati A, Pache J, Dirschinger J, et al.: Primary intracoronary stenting in acute myocardial infarction: long-term clinical and angiographic follow-up and risk factor analysis. Am Heart J 2000, 139:208–216. CrossRef
- Maillard L, Hamon M, Khalife K, et al.: A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2000, 35:1729–1736. CrossRef
- Schömig A, Kastrati A, Dirschinger J, et al.: Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med 2000, 343:385–391. The first valid evidence that PCI in combination with the administration of glycoprotein IIb/IIIa receptor blockers salvages ischemic myocardium to a greater degree than fibrinolytic therapy in the setting of ST-elevation acute MI. CrossRef
- Marzocchi A, Piovaccari G, Marrozzini C, et al.: Results of coronary stenting for unstable versus stable angina pectoris. Am J Cardiol 1997, 79:1314–1318. CrossRef
- Lincoff AM, Califf RM, Moliterno DJ, et al.: Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. N Engl J Med 1999, 341:319–327. CrossRef
- Kimmel SE, Localio AR, Krone RJ, et al.: The effects of contemporary use of coronary stents on in-hospital mortality. J Am Coll Cardiol 2001, 37:499–504. CrossRef
- Neumann FJ, Blasini R, Schmitt C, et al.: Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronaryartery stents in acute myocardial infarction. Circulation 1998, 98:2695–2701.
- The EPISTENT Investigators: Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 1998, 352:87–92. CrossRef
- Neumann FJ, Zohlnhöfer D, Fakhoury L, et al.: Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J Am Coll Cardiol 1999, 34:1420–1426. CrossRef
- Topol EJ, Yadav JS: Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000, 101:570–580.
- Percutaneous coronary intervention in st-elevation myocardial infarction
Current Cardiology Reports
Volume 3, Issue 4 , pp 273-279
- Cover Date
- Print ISSN
- Online ISSN
- Current Medicine Group
- Additional Links
- Author Affiliations
- 1. Section of Cardiology, Boston Medical Center, 88 East Newton Street, 02118, Boston, MA, USA